Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
---|
09/27/2000 | EP0885188B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
09/21/2000 | WO2000055138A1 Method of producing oxcarbazepine (=10,11- dihydro- 10- oxo- 5h- dibenz(b,f)- azepine- 5- carboxamide) and its intermediate products |
09/21/2000 | WO2000055137A1 Compounds and methods for modulation of estrogen receptors |
09/21/2000 | WO2000054759A2 Lxr modulators |
09/21/2000 | WO2000039077A3 Thyroid receptor ligands |
09/21/2000 | CA2367895A1 Compounds and methods for modulation of estrogen receptors |
09/21/2000 | CA2367595A1 Lxr modulators |
09/14/2000 | WO1999063999A8 H1-histamine receptor antagonists |
09/14/2000 | DE19910504A1 Verfahren zur Reinigung von N-substituierten Lactamen A process for purifying N-substituted lactams |
09/13/2000 | EP1033988A1 Parenteral formulations comprising carbamazepine or its derivatives |
09/13/2000 | EP0983248A4 Analogs of duocarmycin and cc-1065 |
09/13/2000 | EP0778883B1 Quarternary substituted bleach activators |
09/13/2000 | EP0641439B1 Reagents and methods for the quantification of imipramine or desipramine in biological fluids |
09/13/2000 | EP0599935B1 Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
09/12/2000 | US6118010 Catalytic reduction of the 1-alkoxycarbonyl-3-oxo-3-phenylpropyl derivative |
09/12/2000 | US6117870 Cyclic amide derivatives |
09/12/2000 | US6117866 For inhibiting platelet aggregation or clot formation and reocclusion of an artery or vein in a mammal following fibrinolytic therapy or angioplasty; for treating stroke, transient ischemia attacks, or myocardial infarction |
09/07/2000 | DE19910403A1 Medicaments containing hydroxy-benzo-cyclopentabenzazepine-dione derivatives, useful as cellular hyperproliferation inhibitors, especially antitumor agents |
09/07/2000 | DE10010189A1 Production of caprolactam, used in nylon manufacture, comprises gas-phase rearrangement of cyclohexanone oxime on a silica or zeolite catalyst treated or reactivated with acid |
09/06/2000 | EP1032556A1 Pharmaceutically active compounds and methods of use |
09/06/2000 | EP1032394A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour |
09/05/2000 | US6114390 An argininamide or ornithinamide compound as treating memory loss, migraine, sleep disorders, pain, cardiovascular diseases, subarachnoidal bleeding, vascular-hypertrophic changes, cerebral and coronary vasospasms |
08/30/2000 | EP1030840A1 Cyclic amine derivatives and their use as drugs |
08/30/2000 | CN1265109A Thiazolobenzoheterocycles, prepn. and medicines containing same |
08/29/2000 | US6110934 Substituted benzamide derivatives and their use as anticonvulsants |
08/29/2000 | US6110913 N-substituted azaheterocyclic carboxylic acids and esters thereof |
08/24/2000 | WO2000049000A1 Dopamine d1 receptor agonist compounds |
08/24/2000 | WO2000048984A1 Process to separate linear alkyl 5-formylvalerate |
08/24/2000 | WO2000048974A1 Stabilised compositions of o- and n-vinyl compounds and the use of ammonium salts as stabilisers |
08/24/2000 | WO2000048601A1 Medicament for treating hypertension |
08/24/2000 | WO2000015992A3 Tube for lining pipes and channels, and a method and device for the production thereof |
08/24/2000 | CA2363695A1 Dopamine d1 receptor agonist compounds |
08/23/2000 | EP1029848A1 Process to separate linear alkyl 5-formylvalerate |
08/23/2000 | CN1264300A Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia |
08/22/2000 | US6107291 Antiinflammatory agent |
08/17/2000 | WO2000047563A1 LACTAM INHIBITORS OF FXa AND METHOD |
08/17/2000 | WO2000047207A1 LACTAM INHIBITORS OF FXa AND METHOD |
08/17/2000 | DE19906316A1 Polymerizable vinyl compositions are stabilized by the addition of optionally substituted ammonium carbonate salts |
08/17/2000 | DE19906310A1 Use of 3-(1-(2-aralkyl-2-carboxyethyl)-1-cyclopentanecarboxamido)-2,3,4,5-tetrahydro-2-oxo-1H-benz(b)azepine-1-acetic acid derivatives for treating hypertension |
08/17/2000 | CA2361919A1 Lactam inhibitors of fxa and method |
08/17/2000 | CA2360305A1 Lactam inhibitors of fxa and method |
08/16/2000 | EP1028108A1 Process for producing epsilon-caprolactam |
08/16/2000 | EP1027337A1 Integrin receptor antagonists |
08/16/2000 | EP0847390B1 A PROCESS FOR THE PREPARATION OF 10-OXO-10,11-DIHYDRO-5H-DIBENZ(b,f)AZEPIN-5-CARBOXAMIDE |
08/16/2000 | CN1055403C Medical ointment for treating scabies |
08/10/2000 | WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors |
08/09/2000 | EP1026158A1 Process for the preparation of 5-carbamoyl-5H-dibenz(b,f)azepine |
08/09/2000 | EP1025087A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
08/09/2000 | CN1262618A NF-KB inhibitors containing as active ingredient phenylmethyl benzoquinone |
08/08/2000 | CA2019053C Curable powder coating compositions containing caprolactam-blocked isocyanates |
08/02/2000 | EP1023073A1 Vitronectin receptor antagonist |
08/01/2000 | US6096885 Exhibit agonist activity for cck-a receptors thereby enabling them to modulate the hormones gastrin and cholecystokinin in mammals. |
08/01/2000 | US6096736 Benzazepine derivatives with vasopressin agonistic activity |
08/01/2000 | US6096735 Benzoheterocyclic derivatives |
08/01/2000 | CA2015034C Piperazine derivatives |
07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
07/27/2000 | WO1999062881A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
07/26/2000 | EP1021190A1 Novel amide derivatives |
07/26/2000 | EP1021189A1 Method for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation |
07/20/2000 | WO2000042040A1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
07/19/2000 | EP1020470A2 Galanthamine derivatives, a process for their preparation and their use as medicaments |
07/19/2000 | EP1020469A2 Galanthamine derivatives, a process for their preparation and their use as medicaments |
07/19/2000 | EP1019383A2 Process for the aminocarbonylation of benzazepines and benzodiazepines |
07/19/2000 | EP1019367A1 Derivatives of 2,5- and 3,5-disubstituted anilines, their preparation and use |
07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
07/13/2000 | WO2000040577A1 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12 |
07/13/2000 | WO2000040564A1 N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase |
07/13/2000 | CA2358955A1 N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase |
07/13/2000 | CA2356689A1 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12 |
07/12/2000 | CN1054380C Condensed cyclic compounds and their use |
07/06/2000 | WO2000039085A1 Process for the production of n-vinyl-2-pyrrolidone by vinylation |
07/06/2000 | WO2000039077A2 Thyroid receptor ligands |
07/06/2000 | WO2000038687A1 Protease inhibitors |
07/06/2000 | WO2000038618A2 SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
07/06/2000 | CA2356671A1 Protease inhibitors |
07/06/2000 | CA2356319A1 Thyroid receptor ligands |
07/06/2000 | CA2347671A1 Succinoylamino benzodiazepines as inhibitors of a.beta. protein production |
07/05/2000 | EP1015425A1 Caprolactam production process |
07/05/2000 | EP1014966A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
07/05/2000 | EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
07/05/2000 | CN1259119A Substituted 3,3-diamino-2-propenenitriles their preparation and use |
07/05/2000 | CN1054125C Process for producing imino-sym-phenylethylene by catalytic dehydrogenation with imido-bibenzil |
06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
06/28/2000 | EP1011679A1 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders |
06/27/2000 | CA2161214C Bleaching compounds comprising substituted benzoyl caprolactam bleach activators |
06/21/2000 | EP1009405A1 Pyrrolidine and piperidine modulators of chemokine receptor activity |
06/21/2000 | EP0888436B1 Solid composition of heterocyclic compounds and/or oxime esters and inert porous carrier materials |
06/21/2000 | CN1257485A Azacyclooctane and heptane derivatives, their preparation and usein therapy |
06/20/2000 | US6077955 Preparation of lactams from aliphatic αω-dinitriles |
06/15/2000 | WO2000033788A2 Substituted nitrogen heterocyclic compounds and therapeutic uses thereof |
06/15/2000 | CA2355296A1 Substituted nitrogen heterocyclic compounds and therapeutic uses thereof |
06/14/2000 | EP1008592A2 Cyclic amide derivatives which inhibit cathepsin K |
06/14/2000 | EP1008346A1 NF-$g(k)B INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT PHENYLMETHYL BENZOQUINONE |
06/14/2000 | EP1007051A1 Integrin receptor antagonists |
06/08/2000 | WO2000033617A1 Oleds containing thermally stable glassy organic hole transporting materials |
06/06/2000 | US6071915 Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia |
06/06/2000 | US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases |
06/06/2000 | US6071901 Treating pain, hyperalgesia and/or inflammatory conditions in which c-fibers play a pathophysiological role; inhibition of neurogenic inflammation involving the release of neuro-peptide from peripheral and central endings of sensory nerves |